Selected research
Industry Research
Transcatheter Heart Valve Therapies Industry Research Report 2026
Market perspective
The global Transcatheter Heart Valve Therapies market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Transcatheter Heart Valve Therapies is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Transcatheter Heart Valve Therapies is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Transcatheter Heart Valve Therapies is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Transcatheter Heart Valve Therapies include Cardiac Dimensions, Mitralign, NeoChord, Edwards Lifesciences, Hanyu Medical, Abbott and Valgen Medtech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Transcatheter Heart Valve Therapies market in terms of revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Transcatheter Heart Valve Therapies Market by Company
Cardiac Dimensions
Mitralign
NeoChord
Edwards Lifesciences
Hanyu Medical
Abbott
Valgen Medtech
Transcatheter Heart Valve Therapies Segment by Type
Replacement Interventional Devices
Restorative Interventional Devices
Transcatheter Heart Valve Therapies Segment by Application
Hospital
Clinic
Transcatheter Heart Valve Therapies Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transcatheter Heart Valve Therapies market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Transcatheter Heart Valve Therapies and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transcatheter Heart Valve Therapies.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Transcatheter Heart Valve Therapies manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Transcatheter Heart Valve Therapies by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Transcatheter Heart Valve Therapies in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Replacement Interventional Devices
- Restorative Interventional Devices
Applications
- Hospital
- Clinic
Companies covered
- Cardiac Dimensions
- Mitralign
- NeoChord
- Edwards Lifesciences
- Hanyu Medical
- Abbott
- Valgen Medtech
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Transcatheter Heart Valve Therapies Market Size (2021-2032)
- 2.2.2 Global Transcatheter Heart Valve Therapies Sales (2021-2032)
- 2.2.3 Global Transcatheter Heart Valve Therapies Market Average Price (2021-2032)
- 2.3 Transcatheter Heart Valve Therapies by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Replacement Interventional Devices
- 2.3.3 Restorative Interventional Devices
- 2.4 Transcatheter Heart Valve Therapies by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Transcatheter Heart Valve Therapies Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Transcatheter Heart Valve Therapies Sales (Units) of Manufacturers (2021-2026)
- 3.3 Global Transcatheter Heart Valve Therapies Revenue of Manufacturers (2021-2026)
- 3.4 Global Transcatheter Heart Valve Therapies Average Price by Manufacturers (2021-2026)
- 3.5 Global Transcatheter Heart Valve Therapies Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Transcatheter Heart Valve Therapies, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Transcatheter Heart Valve Therapies, Product Type & Application
- 3.8 Global Manufacturers of Transcatheter Heart Valve Therapies, Established Date
- 3.9 Global Transcatheter Heart Valve Therapies Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Cardiac Dimensions
- 4.1.1 Cardiac Dimensions Company Information
- 4.1.2 Cardiac Dimensions Business Overview
- 4.1.3 Cardiac Dimensions Transcatheter Heart Valve Therapies Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Cardiac Dimensions Transcatheter Heart Valve Therapies Product Portfolio
- 4.1.5 Cardiac Dimensions Recent Developments
- 4.2 Mitralign
- 4.2.1 Mitralign Company Information
- 4.2.2 Mitralign Business Overview
- 4.2.3 Mitralign Transcatheter Heart Valve Therapies Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Mitralign Transcatheter Heart Valve Therapies Product Portfolio
- 4.2.5 Mitralign Recent Developments
- 4.3 NeoChord
- 4.3.1 NeoChord Company Information
- 4.3.2 NeoChord Business Overview
- 4.3.3 NeoChord Transcatheter Heart Valve Therapies Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 NeoChord Transcatheter Heart Valve Therapies Product Portfolio
- 4.3.5 NeoChord Recent Developments
- 4.4 Edwards Lifesciences
- 4.4.1 Edwards Lifesciences Company Information
- 4.4.2 Edwards Lifesciences Business Overview
- 4.4.3 Edwards Lifesciences Transcatheter Heart Valve Therapies Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Edwards Lifesciences Transcatheter Heart Valve Therapies Product Portfolio
- 4.4.5 Edwards Lifesciences Recent Developments
- 4.5 Hanyu Medical
- 4.5.1 Hanyu Medical Company Information
- 4.5.2 Hanyu Medical Business Overview
- 4.5.3 Hanyu Medical Transcatheter Heart Valve Therapies Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Hanyu Medical Transcatheter Heart Valve Therapies Product Portfolio
- 4.5.5 Hanyu Medical Recent Developments
- 4.6 Abbott
- 4.6.1 Abbott Company Information
- 4.6.2 Abbott Business Overview
- 4.6.3 Abbott Transcatheter Heart Valve Therapies Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Abbott Transcatheter Heart Valve Therapies Product Portfolio
- 4.6.5 Abbott Recent Developments
- 4.7 Valgen Medtech
- 4.7.1 Valgen Medtech Company Information
- 4.7.2 Valgen Medtech Business Overview
- 4.7.3 Valgen Medtech Transcatheter Heart Valve Therapies Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Valgen Medtech Transcatheter Heart Valve Therapies Product Portfolio
- 4.7.5 Valgen Medtech Recent Developments
5 Global Transcatheter Heart Valve Therapies Market Scenario by Region
- 5.1 Global Transcatheter Heart Valve Therapies Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Transcatheter Heart Valve Therapies Sales by Region: 2021-2032
- 5.2.1 Global Transcatheter Heart Valve Therapies Sales by Region: 2021-2026
- 5.2.2 Global Transcatheter Heart Valve Therapies Sales by Region: 2027-2032
- 5.3 Global Transcatheter Heart Valve Therapies Revenue by Region: 2021-2032
- 5.3.1 Global Transcatheter Heart Valve Therapies Revenue by Region: 2021-2026
- 5.3.2 Global Transcatheter Heart Valve Therapies Revenue by Region: 2027-2032
- 5.4 North America Transcatheter Heart Valve Therapies Market Facts & Figures by Country
- 5.4.1 North America Transcatheter Heart Valve Therapies Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Transcatheter Heart Valve Therapies Sales by Country (2021-2032)
- 5.4.3 North America Transcatheter Heart Valve Therapies Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Transcatheter Heart Valve Therapies Market Facts & Figures by Country
- 5.5.1 Europe Transcatheter Heart Valve Therapies Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Transcatheter Heart Valve Therapies Sales by Country (2021-2032)
- 5.5.3 Europe Transcatheter Heart Valve Therapies Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Transcatheter Heart Valve Therapies Market Facts & Figures by Country
- 5.6.1 Asia Pacific Transcatheter Heart Valve Therapies Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Transcatheter Heart Valve Therapies Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Transcatheter Heart Valve Therapies Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Transcatheter Heart Valve Therapies Market Facts & Figures by Country
- 5.7.1 South America Transcatheter Heart Valve Therapies Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Transcatheter Heart Valve Therapies Sales by Country (2021-2032)
- 5.7.3 South America Transcatheter Heart Valve Therapies Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Transcatheter Heart Valve Therapies Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Transcatheter Heart Valve Therapies Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Transcatheter Heart Valve Therapies Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Transcatheter Heart Valve Therapies Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Transcatheter Heart Valve Therapies Sales by Type (2021-2032)
- 6.1.1 Global Transcatheter Heart Valve Therapies Sales by Type (2021-2032) & (Units)
- 6.1.2 Global Transcatheter Heart Valve Therapies Sales Market Share by Type (2021-2032)
- 6.2 Global Transcatheter Heart Valve Therapies Revenue by Type (2021-2032)
- 6.2.1 Global Transcatheter Heart Valve Therapies Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Transcatheter Heart Valve Therapies Revenue Market Share by Type (2021-2032)
- 6.3 Global Transcatheter Heart Valve Therapies Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Transcatheter Heart Valve Therapies Sales by Application (2021-2032)
- 7.1.1 Global Transcatheter Heart Valve Therapies Sales by Application (2021-2032) & (Units)
- 7.1.2 Global Transcatheter Heart Valve Therapies Sales Market Share by Application (2021-2032)
- 7.2 Global Transcatheter Heart Valve Therapies Revenue by Application (2021-2032)
- 7.2.1 Global Transcatheter Heart Valve Therapies Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Transcatheter Heart Valve Therapies Revenue Market Share by Application (2021-2032)
- 7.3 Global Transcatheter Heart Valve Therapies Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Transcatheter Heart Valve Therapies Value Chain Analysis
- 8.1.1 Transcatheter Heart Valve Therapies Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Transcatheter Heart Valve Therapies Production Mode & Process
- 8.2 Transcatheter Heart Valve Therapies Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Transcatheter Heart Valve Therapies Distributors
- 8.2.3 Transcatheter Heart Valve Therapies Customers
9 Global Transcatheter Heart Valve Therapies Analyzing Market Dynamics
- 9.1 Transcatheter Heart Valve Therapies Industry Trends
- 9.2 Transcatheter Heart Valve Therapies Industry Drivers
- 9.3 Transcatheter Heart Valve Therapies Industry Opportunities and Challenges
- 9.4 Transcatheter Heart Valve Therapies Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst